Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease

被引：0
|
作者：
Sierra Morales, M. [1 ,2 ]
Birdi, S. [1 ]
Samaan, M. A. [1 ]
Brown-Clarke, C. [1 ]
Duncan, J. [1 ]
Stanton, A. [1 ]
Koumoutsos, I. [1 ]
Anderson, S. [1 ]
Ray, S. [1 ]
Mawdsley, J. [1 ]
Sanderson, J. [1 ]
Irving, P. M. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England
[2] Hosp Univ Ramon & Cajal, Gastroenterol & Hepatol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P673
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [1] VEDOLIZUMAB DOSE ESCALATION AS A WAY OF RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Birdi, S.
    Sierra Morales, M.
    Samaan, M. A.
    Brown-Clarke, C.
    Stanton, A.
    Ray, S.
    Koumoutsos, I.
    Mawdsley, J.
    Anderson, S.
    Sandersdon
    Irving, P. M.
    [J]. GUT, 2018, 67 : A69 - A70
  • [2] EFFECT OF VEDOLIZUMAB DOSE ESCALATION ON RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S77 - S77
  • [3] Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients
    Razvi, Mohammed A.
    Chowdhury, Reezwana
    Parian, Alyssa
    Melia, Joanna
    Truta, Brindusa
    Brant, Steve
    Dudley-Brown, Sharon
    Lazarev, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S417 - S418
  • [4] Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease
    Vaughn, Byron P.
    Yarur, Andres J.
    Graziano, Elliot
    Campbell, James P.
    Bhattacharya, Abhik
    Lee, Jennifer Y.
    Gheysens, Katherine
    Papamichael, Konstantinos
    Osterman, Mark T.
    Cheifetz, Adam S.
    Cross, Raymond K.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 11
  • [5] PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE
    Levine, Louis
    Gaidos, Jill K.
    Proctor, Deborah D.
    Al Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S703 - S703
  • [6] OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Scoville, Elizabeth A.
    Izmaylov, Michelle L.
    Bennett, Audrey
    Evers, Lauren
    Annis, Kim
    Garrett, Ailish
    Duley, Caroline
    Adams, Dawn W.
    Dalal, Robin L.
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S829 - S830
  • [7] COSTS OF DOSE ESCALATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB AND USTEKINUMAB IN PORTUGAL
    Lopes da Cruz, J. P.
    Faria, M.
    Aleixo, A. S.
    Pereira, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S504 - S505
  • [8] RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Zhang, K. H.
    Singh, H.
    Twardowski, R.
    Lu, C.
    Wan, Y.
    Null, K.
    [J]. VALUE IN HEALTH, 2020, 23 : S143 - S143
  • [9] Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
    Patel, Dipen
    Martin, Stephan
    Luo, Michelle
    Ursos, Lyann
    Lirio, Richard A.
    Kamble, Pravin
    Wang, Song
    [J]. CROHNS & COLITIS 360, 2022, 4 (03)
  • [10] Effect of Ustekinumab Dose Escalation on Recapturing Clinical Response in Patients With Crohn's Disease
    Bundschuh, Mark
    McDonough, Gregory
    Kumar, Priyanka
    Kozuch, Patricia
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S452 - S452
12345